Stockreport

BioTime to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019

BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors
PDF ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic [Read more]